CXCL9 and glioblastoma: In contrast, CXCL9 has been shown to predict good outcomes for cancer patients [43]; HCAR3 and GNG4 exhibit suppressor effects on the process of tumorigenesis in mammary cancer [44, 45] and in GBM [46].